![](https://investorshub.advfn.com/uicon/522650.png?cb=1464431304)
Sunday, April 11, 2021 5:06:51 PM
You just admitted Nasrat did the right thing by selling off the opioids.
Extremely unlikely is NOT 100%. It means there's a chance.
And if that chance happened it would mean BANKRUPTCY for Elite.
Case closed.
The logic of this argument falls in on itself. What dumbass lawyer would sue a company in such dire financial shape that it would immediately result in the end of operations? What would be the point of that? And once again I will ask, for what reason would they be sued? What did they do? Feel free to review in the FDA Orange Book the many companies who still enjoy excellent revenue from their opioid ANDA's without ever being sued for it.
This was a business that was labeled a "going concern" by their auditor because of their lack of revenue, and the CEO sold off their greatest revenue-generating assets in an attempt to decrease an already extremely low risk of opioid litigation. There is no such thing as zero risk. Who would you rather have as the CEO- the guy who panics at low risk and dumps the most valuable assets in the history of the company, or the guy who picked them up for a tiny fraction of their development cost? Even if he chooses to just hold them for now, would you rather have the guy who is looking 2-3 years down the road or the guy who constantly "pivots" from one strategy to another, never delivering what he promises for any of them? Shareholders have learned that when Nasrat talks about buckets, then they should get their shovels. The crap from him just keeps getting deeper and deeper.
What Nostrum got from Elite for $1.2 million:
1. Norco
2. Percocet
3. Dilaudid
4. Methadone
What Elite got from Mikah for $1.2 million:
1. Trimipramine
Case closed.
Occam's razor: the simplest solution is most likely the right one.
Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2023 08:15:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:05:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 09:30:05 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/31/2023 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/17/2023 08:15:16 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM